Legal Marijuana Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 42.02 Bn

Forecast Year, 2035

USD 283.64 Bn

CAGR, 2026 - 2035

21.04%

Report Coverage

Global

What is Legal Marijuana Market Size?

The global legal marijuana market size is estimated at USD 42.02 billion in 2025 and is predicted to increase from USD 51.98 billion in 2026 to approximately USD 283.64 billion by 2035, expanding at a CAGR of 21.04% from 2026 to 2035.

Market Hightlights

• North America led the global market with the highest market share in 2025
• By Type, the medical segment had the biggest market share of 69% in 2025.
• By Product, the buds segment dominated the global market in 2025.
• By Application, the chronic pain segment has held the largest revenue share in 2025.

Market Overview

Marijuana or cannabis has been utilized as a medicine for several years. There is now increasing reception of this plant as a legitimate selection for patients who suffer from medical issues, such as seizures or chronic pain. It is widely employed for the treatment of mental disorders and diseases, migraine, chronic pain conditions, arthritis, cancer treatment, and other medical circumstances. The increasing demand for marijuana in the healthcare industry due to its medicinal properties contributes to market growth in the coming years.

Legal Marijuana Marke Growth Factors

Marijuana or cannabis has been utilized as a medicine in several cultures for many years. There is now mounting reception of the plant as a legitimate selection for patients who suffer from medical issues such as seizures or chronic pain. It is widely employed for the treatment of mental disorders and diseases, migraine, chronic pain conditions, arthritis, cancer treatment, and other medical circumstances.

The application of cannabis for medical uses is gaining impetus across the world due to current legalization in several countries. Medical marijuana is employed for treating chronic conditions including arthritis, cancer, and neurological circumstances like depression, anxiety, epilepsy, Parkinson's, and Alzheimer's disorders. Such a wide scope of application is predicted to promise well for the medical marijuana market growth. Cannabis legalization is frequently observed with dual discernments where its authorization has been met with skepticism related to probable abuse. On the other hand, it is thought that legalization could, in turn, permit individuals to exercise harmless substance usage, whereas also gaining therapeutic profits. As a consequence, there is a snowballing number of nations that are progressively legalizing the practice of cannabis across the world.

Yet, the numerous contradictory judgments of smoking cannabis, which include the composition of continued cough, mucus, and respiratory contaminations like COPD, will act as constraints for the growth of the market.

Until lately, marijuana and its byproducts were widely limited under legislation in nations such as the UK, and the U.S. which specified they had no medicinal value and carried a considerable risk of misappropriation. Policies concerning the usage of cannabis-based goods for medicinal resolves are rapidly altering, and marijuana can be prescribed for therapeutic use in many nations. The FDA has permitted two synthetically made cannabinoid medications dronabinol, and nabilone to cure nausea and sickness from the chemotherapy procedure. Epidiolex(cannabidiol) was permitted in 2018 for healing seizures allied with two infrequent and severe patterns of epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome. Medical cannabis commodities have recently become permissible in Germany, the U.K., Italy, the Netherlands, and Portugal, with France and Spain also on track to allow them soon. This is expected to provide significant new opportunities for treating patients.

The major driver for the upsurge in the marijuana market is the skincare benefits associated with the product. People have long used marijuana to treat ailments. Cannabis-based beauty products show results of them being beneficial in all forms of beauty products. CBD-filled anti-wrinkle beauty products exhibit considerable outcomes just after forty days of usage. CBD can regulate inflammation and oil production, 2 of the motives why acne develops. Going by this, it is clear that the cannabis extract market has a bright future as CBD products can be made to suit all skin types. That is the reason that almost 48% of millennials U.S. say they would buy beauty products with infused CBD oil for skin care. Similarly, 18% of millennials purchase hair care products that contain CBD. Even the best-selling beauty products on e-commerce websites such as Amazon are all-natural brands.

Market Outlook

• Industry Growth Overview: As the trend toward legalization has increased, so will the pace of increase in this market, due to an increase in healthcare acceptance of marijuana use, greater availability of retail sales, and technological advances.
• Sustainability Trends: Sustainability is becoming increasingly important in the cannabis industry. Companies are making investments in growing landscapes that are energy efficient, systems that reduce water use during irrigation, packages that can be recycled, and environmental sustainability by eliminating carbon emissions.
• Global Expansion: As medical cannabis is legalized in additional geographical areas and Adult-use cannabis is controlled through regulatory frameworks, marijuana companies will begin selling products globally.
• Startup Ecosystem: Innovation in the cannabis technology and software sector continues to grow and develop with newer technology such as cannabis compliance software, biotechnical development, alternate consumption methods, and the ability to improve supply chain management.

Legal Marijuana Market Trade Analysis

• An establishment of a regulated global network and trade of marijuana is being developed due to licensing frameworks, pharmaceutical compliance standards, and the development of bilateral trade agreements.
• Medical marijuana is currently the most traded product in regard to marijuana due to stakeholders having a more formal recognition of regulatory acceptance.
• Exporting nations are able to maximize profitability by leveraging their cost-efficient growing and climate advantages.
• As a general rule, importing countries prioritize both stringent quality certification regarding the product being imported and a standardization of the formulation of products being imported; thus, their desire for such is reflected in the pricing and logistics of these respective products.

Market Scope

Market Dynamics

Drivers

Changing legal landscape

Many countries in the world are cultivating marijuana as it becomes legalized for medical and recreational use. Moreover, the FDA imposed various guidelines and policies to legalize cannabis and regulate its use. For instance, in July 2024, the U.S. Drug Enforcement Administration proposed new rules stating that medications containing delta-9 THC from the cannabis plant are eligible for approval by the U.S. Food and Drug Administration (FDA). This can positively impact the market. Additionally, many startups in Europe and the U.S. are now focusing on alternative uses of cannabis other than medicinal and recreational uses, thereby driving the market.

Restraint

Higher rate of complications due to frequent use

The frequent use of marijuana can result in paranoia, unpleasant thoughts disorientation, and anxiety. Schizophrenia and temporary psychosis are more likely to be experienced by people who often use marijuana. Moreover, several regulations limit the market growth. For instance, FDA has not approved a marketing application for cannabis for the treatment of diseases, and approved products are only available with a prescription from a healthcare provider.

Opportunity

Skincare benefits associated with the product

Skincare benefits associated with marijuana fuel the market. Marijuana has been used for many years to treat ailments. Cannabis-based beauty products show benefits in all forms of beauty products. CBD-filled anti-wrinkle beauty products exhibit considerable outcomes just after forty days of usage. CBD can regulate inflammation and oil production, reducing the development of acne.

• In June 2024, NOW, a manufacturer of natural products launched THC-free CBD topical products. The products include CBD massage oil, CBD balm, and CBD joint & muscle cream hat are formulated with hemp and botanical ingredients.

Segment Insights

Type Insights

Depending on type, the medical segment seized the foremost revenue stake of more than 69% in 2025, due to the rising acceptance of cannabis as a pharmaceutical product for the treatment of severe medical situations. Moreover, the snowballing necessity for pain management therapies coupled with the creasing disease burden of chronic pain amongst elders is predictable to lift the demand for medical marijuana in the market.

The adult use segment is anticipated to grow at the fastest rate over the forecast period. The growth of the segment is attributed to changing customer attitudes toward recreational marijuana. Furthermore, in developed countries like Canada and the U.S., medicinal and adult-use cannabis have both been legalized, thereby boosting the segment.

Product Insights

Different types of products assessed in the legal marijuana market are oils, buds, and tinctures. Among all, marijuana buds accounted for the majority of the market revenue share in 2025. The buds are economical as compared to other types of products, making them more popular. Oils are the second-most revenue-generating product type. Its application in treating nausea and cancer is the major reason for its wide use.

Buds are key plant products and are easily obtainable deprived of any processing, which makes them comparatively reasonable for patients with low-income. Furthermore, the quick onset of action of smoking buds than other kinds is expected to supplement the growth of this segment further.

The oils segment is anticipated to grow at the fastest rate during the projected period. Oils derived from marijuana help in treating nausea due to cancer, which is the major factor boosting the adoption of oils. The growth of the segment is further attributed to the growing utilization of cannabis-based products for medical use. Moreover, oils helps in treating sleep disorders and cures stress and anxiety. Thus, many patients prefer marijuana oil over flowers.

Application Insights

Among different medical applications, in 2025, the chronic pain segment dominated the global legal marijuana market due to the occurrence of a huge patient pool. Chronic pain lasts for more than three months. Chronic pain can also interfere with daily activities. However, the moderate use of marijuana products can help to reduce chronic pain in a short time. The increased demand for pain management in a large patient base suffering from chronic disorders contributed to segmental growth.

The mental disorder segment is anticipated to register rapid growth during the projection period due to the rising number of patients undergoing mental disorders like depression, Alzheimer's illness, and anxiety disorder. However, marijuana can alter the different states of consciousness after consuming it and thus relieve the symptoms associated with mental disorders.

Regional Insights

What is the U.S. Legal Marijuana Market Size?

The U.S. legal marijuana market size is valued at USD 25.06 billion in 2025 and is expected to reach USD 150.89 billion by 2035, growing at a CAGR of 19.67% from 2026 to 2035.

North America governed the global market on account of the cumulative legalization of cannabis for both recreational and medical purposes. There is a budding consciousness among consumers concerning the health assistance offered by cannabis.

North America accounted for more than 85% of the global revenue. Increasing legalization and favorable government guidelines in Canada and the U.S. are the key factors contributing to the growth of the legal marijuana market in North America. Moreover, the 2018 Farm Bill that legalizes hemp-based goods in the United States is playing an important role in boosting the demand for legal marijuana.

In the U.S. around 33 states have endorsed marijuana in some capacity, creating new employment and economic openings within the legal marijuana industry. With more states anticipated to advance cannabis legalization actions in the years to come, and federal lawmakers seeing restructuring legislation, more Americans will soon be able to legally access cannabis.

Furthermore, Europe medical cannabis market is anticipated to perceive significant growth during the estimated timeframe. Legalization of medical usage of marijuana in Germany in 2017 fashioned a domino effect on other European nations for the commencement of marijuana-associated research programs. This also directed the legalization of the medicinal application of cannabis in the UK. With public backing principally in support of the legalization of medical cannabis, most of patients in Europe are hopeful to have legal access to cannabis. Furthermore, varied demographics and a huge patient population are appealing to numerous medical marijuana players in Europe, thus leading to industry development. In February 2019, Thailand became the foremost country in Southeast Asia to permit the consumption and growth of medical marijuana, opening its first legal cannabis greenhouse.

Europe was the second most prominent market majorly due to changes in the legalization of marijuana and increasing awareness regarding its medicinal use. The ‘Cannabis as Medicine Act passed by Germany in March 2017 created a mechanism for quality-controlled cannabis supply, including domestic production. Patients for whom all other treatment options have been exhausted can get a medical prescription for dried cannabis flowers and extracts of standardized quality at a pharmacy. The prescription of cannabis preparations is not restricted to particular specialists, nor is their usage restricted to explicit medical indications.

Marijuana is used in Australia for medicinal and recreational use, with a testified one-third of all Australians aged 22 or older (33.5%, about 5.8 million) having tried marijuana and around 1 million people using it annually. It is estimated that about 750,000 Australians use marijuana every week and approximately 300,000 uses it on a daily basis. Australia has one of the highest rates of marijuana prevalence in the world, and Australia's native population has higher levels of marijuana use. On 24 February 2016, Australia legalized medicinal cannabis at the federal level. On 25 September 2019, the Australia Capital Territory (ACT) passed a bill to make the ACT the first region in Australia to legalize marijuana for personal use as of 31 January 2020.

Cities Consume the Most Cannabis in the World

Value Chain Analysis

• Cultivation and Development of Genetics: Cultivators are licensed to cultivate cannabis and focus on a few essential activities. They optimize the genetic profile of cannabis strains by breeding with high-yielding, consistent strains while maintaining strict regulatory and quality benchmarks.
• Processing, Testing, and Product Formulation: Manufacturers transform cannabis into various product types, including oils, edibles, concentrates, and health/wellness products. Cannabis is continually lab-tested to ensure that it meets safety, potency, and compliance standards.
• Distribution and Retail Channels: Distributors (wholesale and retail), dispensaries/pharmacies, and online marketplaces all have to manage compliant logistics, inventory flow, and customer service interactions.

Legal Marijuana Market Companies

• Tilray Brands: Sells both medicinal and adult-use cannabis products in a variety of forms (dried flowers, extracts, edibles, infused drinks) in all regulated global territories
• Canopy Growth: Canopy rowth also produces a range of products within its four areas (recreational and medical to CBD wellness and premium lifestyle) and has positioned strong brand images for each segment.
• Curaleaf: Curaleaf grows, processes, and sells cannabis as a medicinal and recreational product. Each company has various approaches to grow, test, and distribute cannabis-based products.

Other Major Key Players

• Aurora Cannabis
• GW Pharmaceuticals, plc.
• Organigram Holding, Inc.
• Canopy Growth Corporation
• Maricann Group, Inc.
• Aphria, Inc.
• Maricann Group, Inc.
• The Cronos Group
• Tilray
• ABcannMedicinals, Inc.
• Lexaria Corp.

Global Initiatives

• In January 2025, the Himachal Pradesh cabinet approved the report of a committee recommending the controlled cultivation of cannabis for industrial, scientific, and medicinal purposes, setting the stage for its legalisation in the state. Also, in response to increasing demand for cannabis cultivation and global recognition of its medicinal, agricultural, and industrial value, the Himachal Pradesh government, led by Chief Minister Sukhvinder Singh Sukhu, approved a pilot project for cannabis (hemp) farming. (Source: https://currentaffairs.adda247.com) (https://indianexpress.com)
• In April 2025, the Netherlands expands the state-run experiment for legal cannabis sales. While growing cannabis is still illegal, cannabis shops known as coffeeshops in 10 municipalities will be allowed to sell marijuana from 10 licensed producers. (Source: https://www.fastcompany.com)
• In May 2025, New York officials launched a new online map that's meant to help adults locate licensed marijuana retailers—one of their latest efforts to encourage consumers to buy their cannabis from the regulated market. After the legalization of illicit marijuana shops, the governor and the Office of Cannabis Management (OCM) have prioritized educating the public about the need to purchase their products from licensed dispensaries as a health and safety imperative. (Source: https://www.marijuanamoment.net)

Segments Covered in the Report

By Marijuana Type

• Medical
• Adult Use

By Product Type

• Oils
• Buds
• Tinctures

By Application

• Mental Disorders
• Chronic Pain
• Cancer
• Others

By Regional

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America